] I was reminded of that wisdom this week after the
] National Institutes of Health, in a fit of ethical
] repurification, announced that it would no longer allow
] its researchers to hold significant financial interests
] in, receive consulting fees from, give paid speeches to
] or exchange bodily fluids with employees of any drug or
] biotech companies.